Cargando…
Endotoxin activity assay and polymyxin B hemoperfusion use in a cohort of critically ill patients
Autores principales: | Cutuli, SL, De Pascale, G, Alicino, V, Cicconi, S, Di Gravio, V, Silvestri, D, Giacobelli, D, Gasperin, E, Marsili, S, Vallecoccia, MS, Antonelli, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070020/ http://dx.doi.org/10.1186/cc13598 |
Ejemplares similares
-
Clinical outcome of septic patients with undetectable vitamin D levels at ICU admission
por: De Pascale, G, et al.
Publicado: (2015) -
Polymyxin B hemoperfusion in high endotoxin activity level septic shock patients
por: Monti, G, et al.
Publicado: (2008) -
Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry
por: Cutuli, Salvatore Lucio, et al.
Publicado: (2016) -
Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed?
por: Honore, Patrick M., et al.
Publicado: (2018) -
Polymyxin B-immobilized fiber column hemoperfusion has the ability of endotoxin removal during 24 hours
por: Mitaka, C, et al.
Publicado: (2012)